Apotex Research Private Limited Ramipril Export Data — India (DGFT 2022–2026)

Name: Apotex Research Private Limited Ramipril Export Records India — #11 Exporter, 65 Shipments, $2.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ramipril

India Pharmaceutical Trade Intelligence

$89.8M177 Suppliers93 CountriesHS 30049071

ExportsIndia → UNITED KINGDOM35.0%India → FRANCE23.2%

ImportsMALTA → India$520.7K GERMANY → India$469.4K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: CSP VIATRIS

Apotex Research Private Limited — Ramipril Exporter #11 | $2.3M Trade Value | TransData Nexus | TransData Nexus

Apotex Research Private Limited — Ramipril Exporter Profile

Indian Pharmaceutical Exporter · #11 for Ramipril · $2.3M export value · DGFT Verified

Apotex Research Private Limited is the #11 Indian exporter of Ramipril with $2.3M in export value and 65 verified shipments. Apotex Research Private Limited holds a 2.6% market share in Ramipril exports across 1 countries. The company exports 12 pharmaceutical products worth $56.3M across 4 therapeutic categories.

Apotex Research Private Limited — Ramipril Export Profile: Buyers & Destinations

Apotex Research Private Limited Ramipril export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Ramipril?

Country	Value	Shipments	Share
UNITED KINGDOM	$31.4M	1,302	36.4%
FRANCE	$20.8M	549	24.1%
UNITED STATES	$12.9M	611	14.9%
CANADA	$5.6M	514	6.4%

Who Are the Top Buyers of Ramipril from India?

Buyer	Country	Value	Orders
WOCKHARDT UK LIMITED	UNITED KINGDOM	$6.7M	276
CRESCENT PHARMA LTD	UNITED KINGDOM	$5.8M	191
BROWN AND BURK UK LIMITED	UNITED KINGDOM	$4.0M	125
ZENTIVA ITALIA SRL	ITALY	$3.8M	169
M/S CRESCENT PHARMA LTD.	UNITED KINGDOM	$3.1M	208
MILPHARM LIMITED,	UNITED KINGDOM	$2.6M	52
CSP VIATRIS SANTE AT CSP- LAB,	FRANCE	$2.2M	44
APOTEX INC,	CANADA	$1.8M	45
SANOFI SAGLIK URUNLERI LTD STI	TURKEY	$1.1M	22
CSP VIATRIS SANT? AT CSP- LAB	FRANCE	$1.0M	20

India's Ramipril is purchased by 389 buyers worldwide. The top buyer is WOCKHARDT UK LIMITED (UNITED KINGDOM), followed by CRESCENT PHARMA LTD and BROWN AND BURK UK LIMITED.

How Does Apotex Research Private Limited Compare to Nearest Ramipril Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	AUROBINDO PHARMA LIMITED	$4.0M	276	8	$14.6K
10	LUPIN LIMITED	$3.6M	155	1	$23.4K
11	APOTEX RESEARCH PRIVATE LIMITED ★	$2.3M	65	1	$35.3K
12	IPCA LABORATORIES LIMITED	$1.3M	244	5	$5.4K
13	IND-SWIFT LIMITED	$1.2M	42	2	$28.1K

Apotex Research Private Limited ranks #11 among 177 Indian Ramipril exporters. Average shipment value of $35.3K compared to the market average of $466.2K. The closest competitors by value are AUROBINDO PHARMA LIMITED and LUPIN LIMITED.

Which Indian Ports Ship Ramipril Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	658	13.2%
JNPT/ NHAVA SHEVA SEA	553	11.1%
SAHAR AIR CARGO ACC (INBOM4)	305	6.1%
SAHAR AIR	291	5.8%
JNPT	271	5.4%
DELHI AIR CARGO ACC (INDEL4)	214	4.3%
DELHI AIR	201	4.0%
VIZAG SEA	194	3.9%

Geopolitical & Trade Policy Impact on Apotex Research Private Limited's Ramipril Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Apotex Research Private Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, resulting in higher shipping costs and potential delays for goods transiting this critical route. Such disruptions can impact the timely delivery of pharmaceutical products to key markets, necessitating strategic adjustments in logistics and supply chain management.

Conversely, ongoing trade tensions between the United States and China have prompted the U.S. to diversify its import sources, creating opportunities for Indian pharmaceutical companies to capture a larger share of the American market. Apotex Research, with its established export portfolio, is well-positioned to leverage this shift.

In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Indian pharmaceutical companies must invest in robust quality assurance systems to meet these standards. Apotex Research's adherence to Good Manufacturing Practices (GMP) and its commitment to quality position it favorably to navigate these regulatory landscapes and maintain its foothold in the EU market.

Apotex Research Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. Apotex Research Private Limited's operations are aligned with the stringent requirements set forth by agencies such as the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Medicines Agency (EMA). The company's commitment to maintaining high-quality manufacturing practices ensures its products meet global safety and efficacy standards.

The evolving regulatory environment necessitates continuous investment in quality control and assurance processes. Apotex Research's proactive approach to compliance not only facilitates market access but also enhances its reputation as a reliable supplier in the global pharmaceutical industry.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ramipril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Apotex Research Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 93+ countries, 389+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ramipril

Ramipril

Apotex Research Private Limited — Ramipril Exporter Profile

Apotex Research Private Limited — Ramipril Export Profile: Buyers & Destinations

Where Does India Export Ramipril?

Who Are the Top Buyers of Ramipril from India?

What Is India's Total Ramipril Export Value and How Much Does Apotex Research Private Limited Contribute?

What Is the Average Shipment Value for Apotex Research Private Limited's Ramipril Exports?

How Does Apotex Research Private Limited Compare to Other Indian Ramipril Exporters?

Regulatory Requirements: Exporting Ramipril to Key Markets

United Kingdom — MHRA

United States — FDA

How Does Apotex Research Private Limited Compare to Nearest Ramipril Exporters?

Which Indian Ports Ship Ramipril Exports?

What Other Cardiovascular Products Does Apotex Research Private Limited Export?

Geopolitical & Trade Policy Impact on Apotex Research Private Limited's Ramipril Exports

Apotex Research Private Limited — Regulatory Compliance & Quality Standards

About Apotex Research Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ramipril Export Data from Apotex Research Private Limited

Ramipril Stats

Company Overview

Top Products by Apotex Research Private Limited

Related Analysis

Need Detailed Export Data?

Data Source